Compounds > n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine
Page last updated: 2024-09-03

n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine and Cardiotoxicity

n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine has been researched along with Cardiotoxicity in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Al Haleem, EN; El-Bakly, WM; El-Demerdash, E; Galal, A1

Other Studies

1 other study(ies) available for n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine and Cardiotoxicity

ArticleYear
Selective A3 adenosine receptor agonist protects against doxorubicin-induced cardiotoxicity.
    Cancer chemotherapy and pharmacology, 2016, Volume: 77, Issue:2

    Topics: Adenosine; Animals; Antibiotics, Antineoplastic; Cardiotonic Agents; Cardiotoxicity; Doxorubicin; Hemodynamics; Immunohistochemistry; Male; Myocardium; Oxidative Stress; Rats; Rats, Wistar; Receptor, Adenosine A3

2016